CDKN2A and cancer: In addition, we adapted the PDG-Ink4a model to express the model antigen chicken ovalbumin (OVA) in cancer cells, thereby generating an immunogenic PDG-driven GEMM (PDG-Ink4a-OVA; Extended Data Fig. 2a).